These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 14711479

  • 1. The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.
    Jones ME, Blosser-Middleton RS, Thornsberry C, Karlowsky JA, Sahm DF.
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):579-86. PubMed ID: 14711479
    [Abstract] [Full Text] [Related]

  • 2. The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.
    Jones ME, Blosser-Middleton RS, Critchley IA, Thornsberry C, Sahm DF, Yamakita J, Akasaki M, Karlowsky JA.
    Chemotherapy; 2002 Dec; 48(5):232-7. PubMed ID: 12476039
    [Abstract] [Full Text] [Related]

  • 3. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.
    Felmingham D, Washington J.
    J Chemother; 1999 Feb; 11 Suppl 1():5-21. PubMed ID: 10207769
    [Abstract] [Full Text] [Related]

  • 4. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D, Reinert RR, Hirakata Y, Rodloff A.
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN, Fritsche TR, Sader HS.
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [Abstract] [Full Text] [Related]

  • 6. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM, Stilwell MG, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [Abstract] [Full Text] [Related]

  • 7. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M, Gales AC, Pignatari AC, Jones RN, Sader HS.
    Microb Drug Resist; 2006 Sep; 12(2):91-8. PubMed ID: 16922623
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF, Brown NP, Thornsberry C, Jones ME.
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [Abstract] [Full Text] [Related]

  • 9. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG, Brown SD, Farrell DJ.
    Ann Clin Microbiol Antimicrob; 2008 Jan 11; 7():1. PubMed ID: 18190701
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
    Thornsberry C, Brown NP, Draghi DC, Evangelista AT, Yee YC, Sahm DF.
    Postgrad Med; 2008 Sep 11; 120(3 Suppl 1):32-8. PubMed ID: 18931469
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.
    Critchley IA, Blosser-Middleton RS, Jones ME, Karlowsky JA, Karginova EA, Thornsberry C, Sahm DF.
    Int J Antimicrob Agents; 2002 Aug 11; 20(2):100-7. PubMed ID: 12297358
    [Abstract] [Full Text] [Related]

  • 12. [Epidemiological study of levofloxacin-resistant Streptococcus pneumoniae isolated from 2003 through 2006 in Japan].
    Sohma M, Yokozawa I, Kaneko S, Satake S.
    Kansenshogaku Zasshi; 2009 Mar 11; 83(2):113-9. PubMed ID: 19364038
    [Abstract] [Full Text] [Related]

  • 13. Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
    Baek JY, Kang CI, Kim SH, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.
    Diagn Microbiol Infect Dis; 2018 Jul 11; 91(3):287-290. PubMed ID: 29540263
    [Abstract] [Full Text] [Related]

  • 14. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, Mpembe R, Quan V, Whitelaw A, Hoffmann R, Govender N, Meiring S, Smith AM, Schrag S, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA).
    Lancet; 2008 Mar 29; 371(9618):1108-13. PubMed ID: 18359074
    [Abstract] [Full Text] [Related]

  • 15. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
    Sunagawa S, Fujita J, Higa F, Tateyama M, Haranaga S, Nakasone I, Yamane N, Uno T.
    J Antibiot (Tokyo); 2011 Aug 29; 64(8):539-45. PubMed ID: 21587266
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
    Kays MB, Lisek CR, Denys GA.
    Int J Antimicrob Agents; 2007 Mar 29; 29(3):289-94. PubMed ID: 17240118
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.